- Home
- NYMTL vs SIGA Comparison
NYMTL vs SIGA Comparison
Compare NYMTL & SIGA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NYMTL
- SIGA
- Stock Information
- Founded
- NYMTL N/A
- SIGA 1995
- Country
- NYMTL United States
- SIGA United States
- Employees
- NYMTL 70
- SIGA N/A
- Industry
- NYMTL Real Estate Investment Trusts
- SIGA Biotechnology: Pharmaceutical Preparations
- Sector
- NYMTL Real Estate
- SIGA Health Care
- Exchange
- NYMTL Nasdaq
- SIGA Nasdaq
- Market Cap
- NYMTL N/A
- SIGA 422.9M
- IPO Year
- NYMTL N/A
- SIGA 1997
- Fundamental
- Price
- NYMTL $21.51
- SIGA $6.69
- Analyst Decision
- NYMTL
- SIGA
- Analyst Count
- NYMTL 0
- SIGA 0
- Target Price
- NYMTL N/A
- SIGA N/A
- AVG Volume (30 Days)
- NYMTL N/A
- SIGA 405.0K
- Earning Date
- NYMTL N/A
- SIGA 07-31-2025
- Dividend Yield
- NYMTL N/A
- SIGA 8.97%
- EPS Growth
- NYMTL N/A
- SIGA N/A
- EPS
- NYMTL N/A
- SIGA 0.67
- Revenue
- NYMTL N/A
- SIGA $120,330,310.00
- Revenue This Year
- NYMTL N/A
- SIGA N/A
- Revenue Next Year
- NYMTL N/A
- SIGA $95.31
- P/E Ratio
- NYMTL N/A
- SIGA $9.97
- Revenue Growth
- NYMTL N/A
- SIGA N/A
- 52 Week Low
- NYMTL N/A
- SIGA $4.95
- 52 Week High
- NYMTL N/A
- SIGA $12.83
- Technical
- Relative Strength Index (RSI)
- NYMTL 44.89
- SIGA 62.39
- Support Level
- NYMTL $21.00
- SIGA $6.34
- Resistance Level
- NYMTL $21.84
- SIGA $6.81
- Average True Range (ATR)
- NYMTL 0.20
- SIGA 0.26
- MACD
- NYMTL -0.05
- SIGA 0.02
- Stochastic Oscillator
- NYMTL 51.00
- SIGA 85.00
About NYMTL New York Mortgage Trust Inc. 6.875% Series F Fixed-to-Floating Rate Cumulative Redeemable Preferred Stock $0.01 par value per share
New York Mortgage Trust Inc is a real estate investment trust for federal income tax purposes, in the business of acquiring, investing in, financing and managing mortgage-related and residential housing-related assets. The company's investment portfolio consists of Structured multi-family property investments such as multi-family CMBS an preferred equity in, and mezzanine loans to owners of multi-family properties. Distressed residential assets such as residential mortgage loans sourced from distressed markets and non-Agency RMBS. Second mortgages, Agency RMBS, and certain other mortgage-related and residential housing-related assets. Geographically operates in USA states California, New York, Florida, New Jersey, Illinois, maximum from California.
About SIGA SIGA Technologies Inc.
SIGA Technologies Inc is a commercial-stage pharmaceutical company focused on the health security market. The company's main product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by the variola virus. The company derives maximum revenue from United States.